Albemarle Q4 net sales beat estimates

Reuters
02/12
Albemarle Q4 net sales beat estimates

Overview

  • Chemical company's Q4 net sales rose 16%, beating analyst expectations

  • Adjusted loss per share for Q4 missed analyst expectations

  • Adjusted EBITDA for Q4 increased 7%, beating analyst estimates

Outlook

  • Albemarle projects 2026 capital expenditures to be approximately flat year-over-year

  • Company anticipates meaningful free cash flow generation with higher lithium prices

  • Albemarle expects to close Ketjen stake sale in Q1 2026

Result Drivers

  • ENERGY STORAGE GROWTH - Energy Storage segment net sales rose 23% due to higher volumes and pricing

  • KETJEN SALES INCREASE - Ketjen segment net sales increased 14% driven by higher FCC volumes and favorable product mix

  • COST AND PRODUCTIVITY IMPROVEMENTS - Achieved $450 mln in cost and productivity improvements, exceeding initial targets

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Net sales

Beat

$1.43 bln

$1.35 bln (16 Analysts)

Q4 Adjusted EPS

Miss

-$0.53

-$0.41 (18 Analysts)

Q4 EPS

-$3.87

Q4 Adjusted EBITDA

Beat

$268.70 mln

$239.47 mln (17 Analysts)

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 11 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Albemarle Corp is $185.00, about 9.8% above its February 10 closing price of $168.56

Press Release: ID:nPn30DJKJa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10